Together they are introducing four science-based synbiotic concepts to support infant health
Lallemand Health Solutions and dsm-firmenich are joining forces to launch early-life synbiotic solutions, leveraging the synergy of probiotics and human milk oligosaccharides (HMOs).
Unlocking the synergy between probiotics and HMOs to provide infants with the best of start, Lallemand Health Solutions, a pioneer in probiotics, and dsm-firmenich, innovators in nutrition, health and beauty, have announced a new partnership. Together they are introducing four science-based synbiotic concepts to support infant health and development across the following areas:
Gut health: Infant microbiome and gut maturation
Natural defenses: Immune system development
Mental health: Gut-brain axis and cognition
Metabolic health: Growth and development
Helping establish a healthy microbiome: Bridging infant formula and breast milk
These synbiotic solutions aim to establish a healthy microbiome and bridge the gap between the composition and functionality of infant formula and that of breast milk. Promising research demonstrates that HMOs selectively promote the growth of specific probiotic strains and enhance the production of metabolites related to gut health, natural defences, cognition, growth, and development. Lallemand’s probiotic strains for infants have been well-documented in numerous clinical studies, demonstrating both efficacy and safety. By combining these elements, the new synbiotic solutions strive to align infant formula more closely with breast milk—the gold standard for infant nutrition—and contribute to the establishment of a healthy gut microbiome. Brand owners active in the space of infant nutrition can access these synergic synbiotic combinations exclusively through dsm-firmenich, whereas Lallemand Health Solutions will continue driving innovation by proposing these synergistic synbiotic combinations through their food supplement solutions.